- Iran mulls ban on vasectomies, decrease on abortions to bolster population
- CNN op-ed claims right-wingers ‘more deadly than jihadists’
- Classes resume at high school rocked by stabbings
- ABC News accuses Center for Public Integrity of stealing Pulitzer-winning work
- Law firm that cleared N.J. Gov. Christie in ‘Bridgegate’ gave 10K to RGA, which he heads
- PETA ‘hopping mad’ at Michelle Obama for using real eggs at Easter Egg Roll
- Sneaky Nebraska toddler traps self inside claw machine game
- Biden to lead $600 million work force training effort
- Atheists’ Easter taunt to Christians: ‘Jesus is a myth’
- Miley Cyrus hospitalized, cancels Kansas City show
Germany orders recall of some Novartis flu shots
BERLIN (AP) - German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.
The Paul Ehrlich Institute, which is part of the country’s Ministry of Health, said there had been no reports of particle formation in Germany or of any serious side effects during the current flu season.
“However, in the interest of risk prevention and consumer safety it is necessary to cancel the approval for certain vaccines, since the formation of particles in the vaccine and therefore the risk of serious side effects cannot be ruled out,” Institute President Prof. Klaus Cichutek said in a statement.
The decision affects four batches of the influenza vaccine Begripal and one batch of Fluad. It does not affect the seasonal vaccine Optaflu.
Italy’s health ministry banned the sale of four Novartis flu drugs on Wednesday. These included Fluad and Begripal _ sold as Aggripal in Italy _ as well as two others: Influpozzi Adiuvato and Influpozzi Subunita.
Switzerland’s regulator Swissmedic also suspended deliveries of flu vaccines from Novartis as a preventive measure.
Britain’s Medicines and Healthcare products Regulatory Agency said there was no evidence yet to pull the vaccines off the market but added it was gathering further information on the Novartis vaccines.
The Swiss pharmaceutical company said Thursday it was cooperating with the Ministry of Health in Italy, where the vaccines are produced, and was committed to providing vaccines to patients for the current flu season. There had been no adverse effects reported so far from more than 1 million doses of Agrippal/Begripal and Fluad administered, the Basel-based company said.
“Novartis confirms that these particles can occur in the vaccine manufacturing process and is confident that there is no impact on the safety or efficacy of the vaccine,” it said in a statement.
TWT Video Picks
By returning to Christian roots, the nation can achieve greatness once again
- 'Culture of intimidation' seen in Nevada ranch standoff
- GOP writes legislation to deny Attorney General Eric Holder his salary
- Secret U.S. assessments show Afghanistan not ready to govern on own
- Fuel-filled wings, ability to swarm: Pentagon offers glimpse at future of drone fleet
- CARSON: Recovering Tocqueville's vision of American exceptionalism
- Atheists rush to stage Easter display: 'Jesus Christ is a myth'
- U.S. Navy to turn seawater into jet fuel
- Nevada Bundy ranch standoff could leave dirt on Harry Reid reputation
- EDITORIAL: Intolerance at Brandeis silences Muslim dissident Hirsi Ali
- Kirsten Dunst: Actress sparks feminist ire: 'You need a man to be a man'
Celebrity deaths in 2014
Top 10 handguns in the U.S.